MapLight Therapeutics, Inc. (MPLT) has an average rating of Buy and mean price target of $43.23, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $37.06, Change: $+1.07, Percent Change: +2.96%
